REMSleep Holdings, Inc. (RMSL)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.77 Million USD | -45.47% |
| 2022 | -1.21 Million USD | -186.09% |
| 2021 | -425.68 Thousand USD | 9.4% |
| 2020 | -469.84 Thousand USD | 79.94% |
| 2019 | -2.34 Million USD | -695.56% |
| 2018 | -294.38 Thousand USD | 54.81% |
| 2017 | -651.46 Thousand USD | -230.54% |
| 2016 | -197.09 Thousand USD | -128.19% |
| 2015 | -86.37 Thousand USD | 86.06% |
| 2014 | -619.48 Thousand USD | 58.09% |
| 2013 | -1.47 Million USD | -5.3% |
| 2012 | -1.4 Million USD | -1165.7% |
| 2011 | -110.91 Thousand USD | 84.77% |
| 2010 | -728.05 Thousand USD | -2954.57% |
| 2009 | -23.83 Thousand USD | 27.94% |
| 2008 | -33.07 Thousand USD | 12.49% |
| 2007 | -37.79 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -124.22 Thousand USD | 88.26% |
| 2024 Q2 | -296.86 Thousand USD | -138.98% |
| 2023 Q3 | -271.32 Thousand USD | -22.56% |
| 2023 FY | -1.77 Million USD | -45.47% |
| 2023 Q4 | -1.05 Million USD | -289.92% |
| 2023 Q1 | -220.97 Thousand USD | 46.39% |
| 2023 Q2 | -221.39 Thousand USD | -0.19% |
| 2022 Q1 | -154.55 Thousand USD | -35.01% |
| 2022 FY | -1.21 Million USD | -186.09% |
| 2022 Q4 | -412.16 Thousand USD | -34.47% |
| 2022 Q3 | -306.5 Thousand USD | 11.07% |
| 2022 Q2 | -344.64 Thousand USD | -122.99% |
| 2021 Q1 | -94.26 Thousand USD | 56.73% |
| 2021 Q3 | -81.86 Thousand USD | 39.4% |
| 2021 Q4 | -114.47 Thousand USD | -39.84% |
| 2021 FY | -425.68 Thousand USD | 9.4% |
| 2021 Q2 | -135.08 Thousand USD | -43.31% |
| 2020 FY | -469.84 Thousand USD | 79.94% |
| 2020 Q1 | -79.39 Thousand USD | 12.08% |
| 2020 Q2 | -114.47 Thousand USD | -44.19% |
| 2020 Q3 | -58.1 Thousand USD | 49.24% |
| 2020 Q4 | -217.87 Thousand USD | -274.95% |
| 2019 FY | -2.34 Million USD | -695.56% |
| 2019 Q4 | -90.29 Thousand USD | 19.69% |
| 2019 Q3 | -112.44 Thousand USD | 94.62% |
| 2019 Q1 | -49.86 Thousand USD | -112.46% |
| 2019 Q2 | -2.08 Million USD | -4089.74% |
| 2018 Q3 | -242.93 Thousand USD | 20.86% |
| 2018 Q2 | -306.99 Thousand USD | -112.29% |
| 2018 Q1 | -144.61 Thousand USD | 67.86% |
| 2018 FY | -294.38 Thousand USD | 54.81% |
| 2018 Q4 | 400.15 Thousand USD | 264.72% |
| 2017 Q4 | -450 Thousand USD | -839.41% |
| 2017 Q3 | -47.9 Thousand USD | 87.69% |
| 2017 Q2 | -389.06 Thousand USD | 6.17% |
| 2017 Q1 | -414.66 Thousand USD | -147.85% |
| 2017 FY | -651.46 Thousand USD | -230.54% |
| 2016 Q4 | -167.3 Thousand USD | -69321.16% |
| 2016 Q1 | -26.26 Thousand USD | -96.45% |
| 2016 Q2 | -3230.00 USD | 87.7% |
| 2016 Q3 | -241.00 USD | 92.54% |
| 2016 FY | -197.09 Thousand USD | -128.19% |
| 2015 Q1 | -34.16 Thousand USD | -8412.17% |
| 2015 FY | -86.37 Thousand USD | 86.06% |
| 2015 Q4 | -13.36 Thousand USD | -5711.74% |
| 2015 Q3 | -230.00 USD | 99.4% |
| 2015 Q2 | -38.61 Thousand USD | -13.03% |
| 2014 FY | -619.48 Thousand USD | 58.09% |
| 2014 Q4 | 411.00 USD | 100.4% |
| 2014 Q3 | -102.3 Thousand USD | 0.01% |
| 2014 Q2 | -102.31 Thousand USD | 75.36% |
| 2014 Q1 | -415.28 Thousand USD | 51.46% |
| 2013 FY | -1.47 Million USD | -5.3% |
| 2013 Q1 | -206.28 Thousand USD | 83.42% |
| 2013 Q2 | -808.28 Thousand USD | -291.83% |
| 2013 Q3 | -202.06 Thousand USD | 75.0% |
| 2013 Q4 | -855.52 Thousand USD | -323.38% |
| 2012 Q4 | -1.24 Million USD | -2173.43% |
| 2012 FY | -1.4 Million USD | -1165.7% |
| 2012 Q1 | -17.25 Thousand USD | 23.86% |
| 2012 Q2 | -45.02 Thousand USD | -160.96% |
| 2012 Q3 | -54.72 Thousand USD | -21.53% |
| 2011 FY | -110.91 Thousand USD | 84.77% |
| 2011 Q3 | - USD | 100.0% |
| 2011 Q2 | -69.18 Thousand USD | -262.98% |
| 2011 Q1 | -19.06 Thousand USD | 89.63% |
| 2011 Q4 | -22.66 Thousand USD | 0.0% |
| 2010 Q4 | -183.79 Thousand USD | 44.57% |
| 2010 Q3 | -331.56 Thousand USD | -55.88% |
| 2010 Q2 | -212.69 Thousand USD | -6599.18% |
| 2010 Q1 | -3175.00 USD | -638.14% |
| 2010 FY | -728.05 Thousand USD | -2954.57% |
| 2009 Q1 | -12.9 Thousand USD | -282.98% |
| 2009 Q2 | -11.32 Thousand USD | 12.21% |
| 2009 Q4 | 590.00 USD | 395.0% |
| 2009 Q3 | -200.00 USD | 98.23% |
| 2009 FY | -23.83 Thousand USD | 27.94% |
| 2008 Q1 | -6500.00 USD | 16.63% |
| 2008 Q4 | 7050.00 USD | 217.5% |
| 2008 Q3 | -6000.00 USD | 78.28% |
| 2008 FY | -33.07 Thousand USD | 12.49% |
| 2008 Q2 | -27.62 Thousand USD | -325.0% |
| 2007 Q3 | -275.00 USD | 0.0% |
| 2007 Q4 | -7797.00 USD | -2735.27% |
| 2007 FY | -37.79 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -545.901% |
| IR-Med Inc. | -4.91 Million USD | 63.925% |
| Polarean Imaging plc | -12.55 Million USD | 85.89% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 504.318% |
| Avitar, Inc. | 2.73 Million USD | 164.829% |
| AVITA Medical, Inc. | -40.4 Million USD | 95.615% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -152.012% |
| Össur hf. | 87.46 Million USD | 102.026% |
| Zecotek Photonics Inc. | -3.65 Million USD | 51.552% |
| QHSLab, Inc. | -240.15 Thousand USD | -637.699% |
| Wellstar International, Inc. | -1.79 Million USD | 1.285% |
| Össur hf. | 87.46 Million USD | 102.026% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 185.134% |
| Escalon Medical Corp. | -104.47 Thousand USD | -1595.741% |
| Aurora Spine Corporation | -446.19 Thousand USD | -297.055% |
| BrainsWay Ltd. | -4.92 Million USD | 64.042% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 81.271% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 737.288% |
| Vivos Inc. | -2.79 Million USD | 36.572% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.657% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -640.758% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -367.568% |
| Nanomix Corporation | -8.43 Million USD | 79.002% |
| Theraclion SA | -3.48 Million USD | 49.104% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -150.576% |
| Positron Corporation | -1.36 Million USD | -30.196% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 14.204% |
| Lombard Medical, Inc. | -29.33 Million USD | 93.961% |
| ALR Technologies Inc. | -2.94 Million USD | 39.869% |
| Stratec SE | 25.26 Million USD | 107.011% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 4508.057% |
| Heart Tronics, Inc. | 14.46 Million USD | 112.252% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -1369.925% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 91.454% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -228.082% |
| VMS Rehab Systems, Inc. | -68.66 USD | -2580211.681% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 48.752% |
| Ingen Technologies, Inc. | -1.61 Million USD | -9.791% |
| Odyssey Group International, Inc. | 14.26 Million USD | 112.423% |
| United American Healthcare Corporation | -67 Thousand USD | -2544.242% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -334.78% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -179.136% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -194.527% |
| Urologix, Inc. | -6.93 Million USD | 74.435% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -40.236% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 71.722% |
| SS Innovations International, Inc. | -20.66 Million USD | 91.428% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -669.473% |
| Smith & Nephew plc | 425 Million USD | 100.417% |
| NIOX Group Plc | 4.6 Million USD | 138.514% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 561.581% |
| Broncus Holding Corporation | -33.22 Million USD | 94.667% |
| Brain Scientific Inc. | -9.6 Million USD | 81.562% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 81.358% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -2818.733% |